Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 8:00 PM
Ignite Modification Date:
2025-12-24 @ 8:00 PM
NCT ID:
NCT02966704
Eligibility Criteria:
Inclusion Criteria:
* Healthy
* Age: 20 - 35 y
* BMI: 18.5 - 25 kg/m2
* Stable dietary habits
* Veins suitable for cannulation (blood sampling)
Exclusion Criteria:
* Having a history of medical or surgical events that may significantly affect the study outcome
* Medical drug use accept incidental use of paracetamol
* (Chronic) disease which might influence the study outcomes e.g. diabetes mellitus or any other endocrine disorder, active cardiovascular disease, hepatic disease, renal disease, cancer
* Milk protein intolerance
* Alcohol consumption of \>14 (women) or \> 21 (men) units per week
* Drug abuse
* Moderate intense physical activity (exercise) for more than 5 hours/week
* Reported weight loss or weight gain of \> 3 kg in the month prior to pre-study screening
* Reported slimming diet, or medically prescribed diet
* Having a habitual diet with a protein content of \<10 En% \> 30 En%
* Reported vegan or macrobiotic life-style
* Recent blood donation (\<1 month prior to Day 01 of the study)
* Not willing to comply to the controlled dietary intervention guidelines
* Not willing or afraid to give up blood donation during the study
* Personnel of Wageningen University, department of Human Nutrition, their partner and their first and second degree relatives
* Current and within 1 month participation in other research from the Division of Human Nutrition
* Not having a general practitioner
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
35 Years
Study:
NCT02966704
Study Brief:
Protocol Section:
NCT02966704